Biologics are a more complex class of pharmaceuticals to manufacture, package, store and distribute than their chemical counterparts.
Safe handling of highly potent molecules is complex, and the associated regulatory requirements are growing. As a result, pharmaceutical companies recognize the importance of selecting the right partner for the development.
Digital Transformation in the Pharma Industry means accessibility is key, consumers are accustomed to experiencing convenience across all aspects of their lives.
WHITEPAPER: The trend toward biologics and greater investment in small and emerging biotech companies is clearly reflected by our experience at PCI Pharma Services.
PCI Pharma Services built pci | bridge on AWS as part of a larger digital transformation, helping the company to more efficiently provide secure, real-time data to its customers.
A panel of experts from PCI Pharma Services and three Life Sciences companies discuss challenges and opportunities related to the development, clinical phases and commercialization of biologics, offering insights on how to improve sponsor-CDMO
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Start your PCI experience today.Your bridge between life-changing therapies and patients.
